HomeInsightsStock Comparison

Lupin Ltd vs Zenlabs Ethica Ltd Stock Comparison

Lupin Ltd vs Zenlabs Ethica Ltd Stock Comparison

Last Updated on: Jun 25, 2025

Key Highlights

  • The Latest Trading Price of Lupin Ltd is ₹ 1930 as of 24 Jun 15:30.
  • The P/E Ratio of Lupin Ltd changed from 38.1 on March 2021 to 38.5 on March 2024 . This represents a CAGR of 0.26% over 4 yearsThe P/E Ratio of Zenlabs Ethica Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Lupin Ltd changed from ₹ 26713 crore on March 2020 to ₹ 73722 crore on March 2024 . This represents a CAGR of 22.51% over 5 yearsThe Market Cap of Zenlabs Ethica Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Lupin Ltd for the Mar '25 is ₹ 5724 crore as compare to the Dec '24 revenue of ₹ 5821 crore. This represent the decline of -1.67% The revenue of Zenlabs Ethica Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Lupin Ltd for the Mar '25 is ₹ 1378 crore as compare to the Dec '24 ebitda of ₹ 1409 crore. This represent the decline of -2.23% The ebitda of Zenlabs Ethica Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Lupin Ltd changed from ₹ 453.33 crore to ₹ 782.38 crore over 8 quarters. This represents a CAGR of 31.37% The net profit of Zenlabs Ethica Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Lupin Ltd changed from 37.36 % on March 2020 to 15.67 % on March 2024 . This represents a CAGR of -15.95% over 5 yearsThe Dividend Payout of Zenlabs Ethica Ltd changed from 33.21 % on March 2023 to 0 % on March 2024 . This represents a CAGR of -100.00% over 2 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Lupin Ltd

  • Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
  • The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments. Lupin Limited was incorporated in the year 1983 with the name Lupin Chemicals Limited.
  • In March 2001, Lupin Laboratories Limited was amalgamated with the company and the name was changed to Lupin Limited.
  • In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar.

About Zenlabs Ethica Ltd

  • Zenlabs Ethica Limited (Formerly known Neelkanth Technologies Limited) was incorporated in 1993.
  • The Company is one of the top 10 pharmaceutical contract marketing and trading companies in India that markets and distribute a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-Bacterial Drugs, Nutraceuticals, etc., It boasts of a comprehensive global network.
  • It deals into marketing and distribution of pharmaceutical products and has grown to be of India's top pharmaceutical companies in 2019. The Company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada.
  • The strength lies in quality, affordable and branded drugs in enhancing the quality of life of people.
  • Apart from this, it offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India.

Lupin Ltd News Hub

News

Lupin allots 20,653 equity shares under ESOP

Lupin has allotted 20,653 fully paid-up equity shares of Rs 2/- each on 24 June 2025 under...

Read more

24 Jun 2025 19:04

News

Lupin inks licensing deal with Sino Universal pharma for Tiotropium DPI drug in China

As per the agreement, SUP will obtain regulatory approvals for selling Tiotropium DPI in C...

Read more

16 Jun 2025 11:07

News

Lupin gets USFDA nod for Oxcarbazepine ER tablets

Oxcarbazepine ER tablets, 150 mg, 300 mg, and 600 mg are bioequivalent to Oxtellar XR ER t...

Read more

09 Jun 2025 08:23

News

Lupin allots 78,930 equity shares under ESOP

Lupin has allotted 78,930 equity shares under Stock Option plans of the Company. According...

Read more

27 May 2025 15:33

News

Lupin grants 7,337 stock options

Lupin has granted 7,337 stock options on 27 May 2025. Please note that upon vesting, one s...

Read more

27 May 2025 18:42

News

Lupin enters into license and supply agreement with SteinCares

Lupin has entered into a license and supply agreement with SteinCares, a leading specialty...

Read more

26 May 2025 10:27

Zenlabs Ethica Ltd News Hub

News

Zenlabs Ethica to declare Quarterly Results

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 12 May 2025...

Read more

08 May 2025 11:05

News

Zenlabs Ethica to declare Quarterly Results

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 12 May 2025...

Read more

07 May 2025 11:07

News

Zenlabs Ethica to hold board meeting

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 7 February ...

Read more

31 Jan 2025 15:48

News

Zenlabs Ethica to announce Quarterly Result

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 12 November...

Read more

07 Nov 2024 16:58

News

Zenlabs Ethica AGM scheduled

Zenlabs Ethica announced that the 31th Annual General Meeting (AGM) of the company will be...

Read more

30 Sep 2024 10:04

News

Zenlabs Ethica announces board meeting date

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 7 August 20...

Read more

02 Aug 2024 10:30

SWOT Analysis Of Lupin Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Zenlabs Ethica Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Lupin Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Zenlabs Ethica Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Lupin Ltd and Zenlabs Ethica Ltd

Which company has a larger market capitalization, Lupin Ltd or Zenlabs Ethica Ltd?

Market cap of Lupin Ltd is 88,174 Cr while Market cap of Zenlabs Ethica Ltd is 21 Cr

What are the key factors driving the stock performance of Lupin Ltd and Zenlabs Ethica Ltd?

The stock performance of Lupin Ltd and Zenlabs Ethica Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lupin Ltd and Zenlabs Ethica Ltd?

As of June 25, 2025, the Lupin Ltd stock price is INR ₹1930.7. On the other hand, Zenlabs Ethica Ltd stock price is INR ₹32.31.

How do dividend payouts of Lupin Ltd and Zenlabs Ethica Ltd compare?

To compare the dividend payouts of Lupin Ltd and Zenlabs Ethica Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions